![]() |
市场调查报告书
商品编码
1943272
化学资讯学市场-全球产业规模、份额、趋势、机会及预测(按应用、最终用户、地区和竞争格局划分,2021-2031年)Cheminformatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球化学资讯学市场预计将从 2025 年的 43.6 亿美元成长到 2031 年的 86.4 亿美元,复合年增长率达到 12.07%。
该领域利用计算策略来组织和解读化学数据,从而辅助分子资讯的储存、搜寻和建模。市场成长趋势的驱动力在于对精简药物发现流程日益增长的需求,以及处理高通量筛检产生的大量资料集的需求。这一发展势头也得到了业界的大力支持。例如,欧洲製药工业协会联合会(EFPIA)估计,到2023年,欧洲以研发为基础的製药业将在研发方面投入500亿欧元。如此庞大的投入凸显了数位化解决方案在提高研发效率和缩短开发週期方面的重要作用。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 43.6亿美元 |
| 市场规模:2031年 | 86.4亿美元 |
| 复合年增长率:2026-2031年 | 12.07% |
| 成长最快的细分市场 | 化学分析 |
| 最大的市场 | 北美洲 |
然而,市场成长的一大障碍是缺乏兼具化学和资讯科技专业知识的人才。这种专业技能的匮乏阻碍了先进资讯基础设施的成功实施。此外,该行业还面临不同平台间数据标准化不一致的问题,这妨碍了协作研究所需的无缝整合。这些互通性挑战有可能减缓该领域先进技术的采用和应用。
人工智慧和机器学习在药物研发领域的快速应用,大大推动了化学资讯学产业的发展。这些技术使科学家能够预测分子相互作用并优化先导化合物,从而催生了对能够管理复杂数据的高级软体框架的需求。这种技术融合在小分子药物设计领域尤其重要,因为演算法需要分析庞大的化合物库。礼来公司于2024年1月宣布与Isomorphic Labs建立策略伙伴关係就是一个很好的例子。该合作包括4500万美元的预付款,用于推动人工智慧主导的药物设计。此类合作凸显了将计算预测与实验室检验相结合的资讯平台的重要性。
此外,製药公司不断增加的研发投入是推动市场发展的主要动力。为了维持开发平臺的竞争力,各公司正大力投资数位转型工具,以优化研发生命週期。这些资金用于购置关键的筛检和建模软体。根据默克公司2024年2月发布的报告显示,该公司2023财年的研发支出飙升至305亿美元。严格的数据完整性监管要求进一步强化了这一趋势。美国食品药物管理局(FDA)在2023年核准了55种新分子实体,如此大规模的核准需要强大的资讯系统来处理与监管申报相关的严苛资料管理。
全球化学资讯学市场面临的一大障碍是同时精通化学和资讯科技的专业人才短缺。随着生技和製药公司越来越依赖运算技术来建立化合物资料模型,能够理解基础科学知识和复杂资料结构的人才需求远远超过供给。这种人才短缺阻碍了资讯系统的顺利应用,迫使企业推迟关键数位化解决方案的实施。如果缺乏能够跨越不同学科的人才,企业在优化大规模化学资料管理方面将面临挑战,这可能会阻碍关键的研发活动。
近期行业统计数据证实,技能缺口正在扩大,并造成营运瓶颈。根据皮斯托亚联盟(Pistoia Alliance)的数据显示,34%的生命科学实验室认为缺乏熟练人才是采用先进数位技术的主要障碍,高于前一年的23%。技术技能的日益短缺直接限制了市场的持续成长能力。如果企业无法获得管理这些平台所需的人才,化学资讯学带来的效率提升将无法实现,导致研发週期延长,市场成长受限。
向云端原生和SaaS部署模式的转变正在改变全球化学资讯学市场,以扩充性的数位平台取代固定的本地硬体。这种转变使製药公司能够分散其研究活动,并促进地理位置分散的团队之间的顺畅协作。利用云端基础设施,企业可以有效应对化学数据的快速成长,而无需承担传统硬体相关的巨额资本成本。随着主要产业参与者将其数位化营运迁移到云端框架,这种策略转变显而易见。例如,Veeva Systems于2025年6月宣布扩大与AWS的合作,以支援超过50个生命科学应用程序,凸显了该产业对云端原生环境以实现营运柔软性的依赖。
同时,随着业界重心从小分子药物转向复杂的治疗性蛋白质,专为生物製药和大分子设计的专用工具的重要性日益凸显。这一趋势推动了创新资讯科学解决方案的开发,这些解决方案旨在管理生物製药传统系统无法充分处理这些数据。随着研发开发平臺日益侧重于大分子治疗药物,对用于建模和模拟这些实体的专用软体的需求也随之激增。生物製药主导产业的强劲财务预测进一步推动了这个市场发展。 2025年6月,IQVIA人类资料科学研究所发布报告称,到2029年,全球肿瘤治疗支出将达到4,410亿美元,凸显了先进资讯科学技术对于支持这一蓬勃发展领域的迫切需求。
The Global Cheminformatics Market is projected to expand from USD 4.36 Billion in 2025 to USD 8.64 Billion by 2031, achieving a compound annual growth rate of 12.07%. This field utilizes computational strategies to organize and interpret chemical data, supporting the storage, retrieval, and modeling of molecular information. The market's upward trajectory is driven by the growing necessity for streamlined drug discovery processes and the handling of massive datasets generated by high-throughput screening. This momentum is supported by substantial industry funding; for instance, the European Federation of Pharmaceutical Industries and Associations estimated that the research-based pharmaceutical sector invested €50,000 million in R&D across Europe in 2023. Such spending highlights the essential function of digital solutions in maximizing research productivity and shortening development cycles.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 4.36 Billion |
| Market Size 2031 | USD 8.64 Billion |
| CAGR 2026-2031 | 12.07% |
| Fastest Growing Segment | Chemical Analysis |
| Largest Market | North America |
Conversely, market growth faces a significant hurdle due to a shortage of workforce talent holding combined proficiency in chemistry and information technology. This lack of specialized skills hinders the successful deployment of sophisticated informatics infrastructures. Furthermore, the industry struggles with data standardization inconsistencies across various platforms, which impede the seamless integration needed for collaborative scientific efforts. These interoperability challenges threaten to retard the widespread acceptance and application of these advanced technologies within the sector.
Market Driver
The rapid incorporation of AI and machine learning into drug discovery acts as a major propellant for the cheminformatics industry. These technologies empower scientists to forecast molecular interactions and refine lead compounds, creating a need for sophisticated software frameworks capable of managing complex data. This technological convergence is particularly crucial for small molecule design, where algorithms analyze extensive chemical libraries. A case in point is Eli Lilly and Company's January 2024 announcement regarding a strategic partnership with Isomorphic Labs, which included a $45 million upfront commitment to advance AI-led drug design. Such alliances underscore the necessity of informatics platforms to connect computational forecasts with experimental validation in the lab.
Additionally, escalating R&D expenditures by pharmaceutical corporations serve as a primary catalyst for the market. Firms are directing significant funds toward digital transformation tools that optimize the research lifecycle to sustain competitive development pipelines. This financial backing enables the acquisition of essential screening and modeling software. As reported by Merck & Co., Inc. in February 2024, the company's full-year R&D expenses for 2023 surged to $30.5 billion. This trend is further strengthened by regulatory requirements for strict data integrity; the U.S. Food and Drug Administration approved 55 new molecular entities in 2023, a volume that necessitates powerful informatics systems to handle the rigorous data management associated with regulatory submissions.
Market Challenge
A critical obstacle facing the Global Cheminformatics Market is the shortage of professionals who possess dual competency in both chemistry and information technology. As biotechnology and pharmaceutical firms increasingly depend on computational techniques to model compound data, the requirement for staff capable of understanding scientific fundamentals alongside complex data structures has exceeded availability. This talent deficit creates barriers to the seamless implementation of informatics systems, compelling organizations to postpone the rollout of vital digital solutions. Without a workforce equipped to bridge these distinct fields, companies face difficulties in optimizing large-scale chemical data management, effectively halting key research and development endeavors.
Recent industry statistics confirm that this skills gap is widening, creating an operational bottleneck. According to the Pistoia Alliance, 34 percent of life science laboratories identified the lack of skilled personnel as a major impediment to adopting advanced digital technologies in 2025, a rise from 23 percent the prior year. This growing shortage of technical proficiency directly limits the market's capacity to maintain its expansion. If organizations fail to acquire the necessary human capital to manage these platforms, the anticipated efficiency improvements from cheminformatics remain out of reach, leading to prolonged development schedules and constrained market growth.
Market Trends
The shift toward Cloud-Native and SaaS deployment models is transforming the Global Cheminformatics Market by supplanting rigid on-premise hardware with scalable digital platforms. This migration enables pharmaceutical companies to decentralize their research activities, promoting fluid collaboration among dispersed teams. By utilizing cloud infrastructures, organizations can effectively handle the rapid expansion of chemical data without incurring the heavy capital costs linked to traditional hardware. This strategic pivot is highlighted by leading industry players moving their digital operations to cloud frameworks; for instance, Veeva Systems announced in June 2025 an extension of its collaboration with AWS to support over 50 life sciences applications, emphasizing the sector's dependence on cloud-native environments for operational flexibility.
Simultaneously, the rise of specialized tools designed for biologics and large molecules is becoming increasingly significant as the industry shifts focus from small-molecule drugs to complex therapeutic proteins. This trend drives the creation of innovative informatics solutions tailored to manage the intricate structural data of biologics, which older systems cannot sufficiently process. As R&D pipelines place greater emphasis on large-molecule therapies, there is a surging need for specific software to model and simulate these entities. This market progression is bolstered by strong financial forecasts for biologics-dominated sectors; the IQVIA Institute for Human Data Science reported in June 2025 that global spending on oncology is expected to reach $441 billion by 2029, underlining the urgent requirement for advanced informatics to sustain this growing field.
Report Scope
In this report, the Global Cheminformatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Cheminformatics Market.
Global Cheminformatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: